A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis
暂无分享,去创建一个
E. Holland | Eric A. Horne | M. Wagenbach | F. Winkler | L. Wordeman | E. Hamel | N. Stella | P. Diaz | P. Cimino | Cong Xu | N. Wageling | E. Jung | D. Azorin | D. Kumasaka
[1] Andrea Comba,et al. Self-organization in brain tumors: How cell morphology and cell density influence glioma pattern formation , 2019, bioRxiv.
[2] A. M. Houghton,et al. Anti-PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma. , 2019, Neuro-oncology.
[3] H. Monyer,et al. Emerging intersections between neuroscience and glioma biology , 2019, Nature Neuroscience.
[4] Fred A. Hamprecht,et al. ilastik: interactive machine learning for (bio)image analysis , 2019, Nature Methods.
[5] A. Recasens,et al. Lower Tubulin Expression in Glioblastoma Stem Cells Attenuates Efficacy of Microtubule-Targeting Agents. , 2019, ACS pharmacology & translational science.
[6] Sébastien Motsch,et al. 3131 ONCOSTREAMS: NOVEL DYNAMICS PATHOLOGICAL MULTICELLULAR STRUCTURES INVOLVED IN GLIOBLATOMA GROWTH AND INVASION , 2019, Journal of Clinical and Translational Science.
[7] H. Fine,et al. Modeling Patient-Derived Glioblastoma with Cerebral Organoids. , 2019, Cell reports.
[8] Eric A. Horne,et al. Modified carbazoles destabilize microtubules and kill glioblastoma multiform cells. , 2018, European journal of medicinal chemistry.
[9] M. Steinmetz,et al. Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton. , 2018, Trends in cell biology.
[10] L. Rice,et al. Microtubule dynamics: an interplay of biochemistry and mechanics , 2018, Nature Reviews Molecular Cell Biology.
[11] R. Rabadán,et al. Increased HOXA5 expression provides a selective advantage for gain of whole chromosome 7 in IDH wild-type glioblastoma , 2018, Genes & development.
[12] G. Ha,et al. Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism , 2017, OncoTargets and therapy.
[13] Andrea Comba,et al. CSIG-11. ONCOSTREAMS: NOVEL STRUCTURES THAT SPECIFY GLIOMAS’ SELF-ORGANIZATION, ARE ANATOMICALLY DISCRETE, FUNCTIONALLY UNIQUE, AND MOLECULARLY DISTINCT , 2017 .
[14] W. Wick,et al. Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas , 2017, Neuro-oncology.
[15] S. Heiland,et al. Tweety-Homolog 1 Drives Brain Colonization of Gliomas , 2017, The Journal of Neuroscience.
[16] M. Castro,et al. Microtubule targeting agents in glioma. , 2016, Translational cancer research.
[17] D. Liggitt,et al. ST-11: A New Brain-Penetrant Microtubule-Destabilizing Agent with Therapeutic Potential for Glioblastoma Multiforme , 2016, Molecular Cancer Therapeutics.
[18] J. Sarkaria,et al. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma. , 2016, Neuro-oncology.
[19] O. Garaschuk,et al. Brain tumour cells interconnect to a functional and resistant network , 2015, Nature.
[20] J. Lemée,et al. Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone. , 2015, Neuro-oncology.
[21] J. Miller,et al. Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function. , 2014, Bioorganic & medicinal chemistry.
[22] Patrick J. Paddison,et al. Molecular Pathways: Regulation and Targeting of Kinetochore–Microtubule Attachment in Cancer , 2014, Clinical Cancer Research.
[23] Linda Wordeman,et al. Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells , 2014, Nature Cell Biology.
[24] B. Ross,et al. Mathematical Modeling of PDGF-Driven Glioblastoma Reveals Optimized Radiation Dosing Schedules , 2014, Cell.
[25] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[26] T. Lagerweij,et al. Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs. , 2013, Journal of the National Cancer Institute.
[27] S. Attia. Molecular cytogenetic evaluation of the mechanism of genotoxic potential of amsacrine and nocodazole in mouse bone marrow cells , 2013, Journal of Applied Toxicology.
[28] Y. Yonekawa,et al. Patupilone (Epothilone B) for Recurrent Glioblastoma: Clinical Outcome and Translational Analysis of a Single-Institution Phase I/II Trial , 2012, Oncology.
[29] Stephen Yip,et al. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. , 2012, Neuro-oncology.
[30] Timothy J. Mitchison,et al. The proliferation rate paradox in antimitotic chemotherapy , 2012, Molecular biology of the cell.
[31] T. Fojo,et al. Mitosis is not a key target of microtubule agents in patient tumors , 2011, Nature Reviews Clinical Oncology.
[32] K. Jaqaman,et al. Robust single particle tracking in live cell time-lapse sequences , 2008, Nature Methods.
[33] P. Pandolfi,et al. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. , 2008, Genes & development.
[34] H. Varmus,et al. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. , 1998, Genes & development.
[35] M. Jordan,et al. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. , 1992, Journal of cell science.